IS APLASTIC ANAEMIA A PKE‐LEUKAEMIC DISORDER?

British Journal of Haematology

Volumn 77, Issue 4, 1991, Pages 447-452

  Marsh, J C W ^a   Geary, C G ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APLASTIC ANEMIA; HUMAN; LEUKEMIA; NOTE; PRIORITY JOURNAL;

ANEMIA, APLASTIC; HEMATOPOIETIC STEM CELLS; HUMAN; PRELEUKEMIA;

EID: 0025908316     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1991.tb08608.x     Document Type: Article

References (77)

1. Pancytopenia as a clonal disorder of a multipotent hemopoietic stem cell
2. A highly informative X‐chromosome probe M27 β, can be used for determination of tumour clonality
3. The bone marrow failure syndromes
4. Precursors of colony forming cells in humans can be distinguished from colony forming cells by expression of the CD33 and CD34 antigens and light scatter properties
5. Bone marrow transplantation for paroxysmal nocturnal hemoglobulin: eradication of the PNH clone and documentation of complete lymphohemopoietic engraftment
6. Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anaemia
7. International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity
8. Acute myeloid leukemia as the first hematologic manifestation of Fanconi's anemia
9. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens
10. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party
11. The preleukaemic syndrome (haematopoietic dysplasia)
12. Hypersensitivity to X‐irradiation‐induced G2 chromatid damage in dyskeratosis congenita
13. Proposal for the classification of the myelodysplastic syndromes
14. Transitory bone marrow failure. A series of 13 preleukemic cases in children
15. The mouse w/c‐kit locus
16. Late effects on haemopoiesis and life‐shortening
17. Hypoplastic anemia and myeloblastic leukemia following chloramphenicol therapy
18. The aplastic presentation of childhood leukaemia—a feature of common ALL
19. Aplastic anemia. Pathogenesis, diagnosis, treatment and prognosis
20. Severe aplastic anemia. A prospective study on the effect of early marrow transplantation on acute mortality
21. Bone marrow transplantation from identical twins in the treatment of aplastic anaemia: implication for the pathogenesis of the disease
22. Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis
23. Editorial: What do aplastic anemia, paroxysmal nocturnal hemogloburia and hypoplastic leukemia have in common
24. Long‐term mortality after a single course with X‐rays in patients treated for ankylosing spondylitis
25. Conditions controlling the proliferation of haemopoetic stem cells in vitro
26. Stromal cells in haemopoiesis
27. Megakaryoblastic leukaemia and myelofibrosis complicating Fanconi's anaemia
28. Acute leukaemia associated with phenylhutazone treatment: a review of the literature and report of a further case
29. Aplasia‐leukaemia syndrome
30. Congenital defects of the marrow stem cell
31. Differentiation of leukemic cells to polymorphonuclear leucocytes in patients with acute nonlymphocytic leukemia
32. Aplastic anaemia and the hypocellular myelodysplastic syndrome: histomorphological, diagnostic and prognostic features
33. Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of antithymocyte globulin
34. Long‐term culture of aplastic anaemia bone marrow
35. Contribution of the marrow stroma to the pathogenesis of aplastic anaemia
36. Long‐term culture of human hone marrow cells
37. Aplastic anaemia and other types of bone marrow failure
38. Fanconi anaemia—constitutional, familial aplastic anaemia
39. Chromosome abnormalities in the myelodysplastic syndromes
40. Functional changes in marrow stromal cells in aplastic anaemia
41. The haematopoietic growth factor KL is encoded by the SI locus and is the ligand of the c‐kit receptor, the gene product of the W locus
42. Differentiation of normal marrow and HL60 cells induced by antithymocyte globulin
43. Dyskeratosis congenita with pancytopenia
44. Benzene and leukaemia
45. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin
46. Long term haematological complications of thorotrast
47. Human long‐term bone marrow cultures in aplastic anemia
48. Therapy linked leukaemia
49. Clonality studies and long term marrow culture to assess haemopoiesis in aplastic anaemia
50. Characterization of the haemopoietic defect in aplastic anaemia by long‐term bone marrow culture
51. The haematopoietic defect in aplastic anaemia assessed by long‐term marrow culture
52. The occurrence of malignancy in radioactive persons
53. Acute childhood leukaemia presenting as aplastic anaemia: the response to corticosteroids
54. The aplasia–leukaemia syndrome
55. Antilymphocyte globulin therapy enhances impaired function of natural killer cells and lymphokine activated killer cells in aplastic anaemia
56. The effects of antithymocyte globulin on natural killer cells
57. Acquired aplastic anaemia: a PNH‐like disease
58. Pathophysiology of aplastic anaemia
59. Fanconi anaemia oxymethalone, hepatic tumours and chromosome aberations associated with leukaemia transition
60. Cytogenetic study of workers exposed to benzene
61. Long‐term follow‐up of severe aplastic anaemia patients treated with antithymocyte globulin
62. Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults
63. Bone marrow histopathology of patients with severe aplastic anaemia before treatment and at follow‐up
64. Paroxysmal nocturnal haemoglobinuria
65. The syndrome of pancreatic insufficiency and bone marrow dysfunction
66. Clinical aspect of a cluster of 42 patients in South Africa with Fauconi anaemia
67. Prognostic factors for patients with severe aplastic anaemia (SAA) treated with antilymphocyte globulin (ALG)
68. Long‐term survival after marrow transplantation for paroxysmal nocturnal haemogloburia with aplastic anaemia
69. Late haematological complications in severe aplastic anaemia
70. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors
71. Clonal analysis using recombinant DNA probes from the X‐chromosome
72. Identification of a ligand for the c‐kit proto‐oncogene
73. Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: A survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG)
74. Circulatory activated suppressor T lymphocytes in aplastic anemia
75. Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c‐kit tyrosine kinase receptor